Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Not sure if TLT can attack this gene

<< Previous

Bullboard Posts

Next >>

Comment by 3Crowson Dec 06, 2024 7:59pm

171 Views

Post# 36350535

RE:RE:Not sure if TLT can attack this gene

I see 7 "likes" to this post. Mine will be the 8th. I'm wondering how many of us actually understood any of it but boy, does it ever sound like good news for us as investors in this cancer fighting drug!

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly